Investing Profile

Martin Alexander Gershon(10)

CEOInvestorFounderVC
Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio.
gershoncapital.comNew York, New York
Photo of Martin Alexander Gershon, Managing Partner at Endeavor Venture Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Endeavor Venture Funds Managing Partner
$500K - $25.0M
$10.0M
95
CompanyStageDateRound SizeTotal Raised
QuantHealth
Series AAug 2023$2.5M
$18M
Co-investors: Ittai Harel (Pitango Venture Capital)
Viome Life Sciences
Series CAug 2023$10M
$10M
Fertifa
Seed Jun 2023$650K
$7.7M
Co-investors: Deepali Nangia (Speedinvest), Malin Posern (Passion Capital), Manuel Antunes (MSM), Itxaso del Palacio (Notion Capital), Eileen Burbidge (Passion Capital), Jonathan Lenson, Mike Hudack, Adam Knight, Tom Blomfield
Alto Neuroscience
Series BJan 2023$7M
$130M
Co-investors: Michael Liang (Baird Capital), Stephen Hays (What If Ventures), Christian Angermayer (Presight Capital), Tim Kendall
Cardiosense
Series ADec 2022$3M
$18M
Co-investors: Daniel Gottlieb (Broadview Ventures), Jeff Terrell (Hatteras Venture Partners)
PVmed
Series BDec 2022$70K
$70K
SaVia Health
SeedDec 2022$1M
$10M
Co-investors: Eric King (Intel Capital)
BehaVR
Series BDec 2022$1M
$2M
Co-investors: Enke Bashllari (Arkitekt Ventures), Kelby Price (Keyhorse Capital)